This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA to Convene Pharmacy Compounding Advisory Committee in July FDA Peptide Reclassification 2026: What Researchers Want